Oncotarget

Vol 10, No 6

January 18, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 6 of Oncotarget features Figure 5, "AKT-specific inhibitor MK2206 decreases cell viability, spheroid formation, and migration of SETD2 deficient ccRCC-derived cells," by Terzo, et al.

Table of Contents

News

CDK4/6 inhibition alone and in combination for non-small cell lung cancer

CDK4/6 inhibition alone and in combination for non-small cell lung cancer

https://doi.org/10.18632/oncotarget.26545

Jose Pacheco,  and Erin Schenk
618-619
PDF  |  How to cite  |  Order a Reprint

Editorial

DNA polymerases as chemotherapy targets: promise and challenges

DNA polymerases as chemotherapy targets: promise and challenges

https://doi.org/10.18632/oncotarget.26572

Kristin A. Eckert,  and Ryan P. Barnes
620-621
PDF  |  How to cite  |  Order a Reprint

Role of transcription-regulating kinase CDK8 in colon cancer metastasis

Role of transcription-regulating kinase CDK8 in colon cancer metastasis

https://doi.org/10.18632/oncotarget.26593

Jiaxin Liang, Mengqian Chen, Eugenia V. Broude,  and Igor B. Roninson
622-623
PDF  |  How to cite  |  Order a Reprint

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins

https://doi.org/10.18632/oncotarget.26594

Arya Amini,  and Sana D. Karam
624-625
PDF  |  How to cite  |  Order a Reprint

The dawn of a new era in treating T-PLL

The dawn of a new era in treating T-PLL

https://doi.org/10.18632/oncotarget.26595

Alexandra Schrader, Till Braun,  and Marco Herling
626-628
PDF  |  How to cite  |  Order a Reprint

AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategy

AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategy

https://doi.org/10.18632/oncotarget.26602

Saranya Chidambaranathan Reghupaty, Rachel Mendoza,  and Devanand Sarkar
629-630
PDF  |  How to cite  |  Order a Reprint

Modeling the prevalent germline TP53 R337H mutation in mouse

Modeling the prevalent germline TP53 R337H mutation in mouse

https://doi.org/10.18632/oncotarget.26603

Ji-Hoon Park, Ping-Yuan Wang,  and Paul M. Hwang
631-632
PDF  |  How to cite  |  Order a Reprint

Research Papers

Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma

Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma

https://doi.org/10.18632/oncotarget.26551

Yutaka Takahashi, Tomohiro Yasui, Kazumasa Minami, Keisuke Tamari, Kazuhiko Hayashi, Keisuke Otani, Yuji Seo, Fumiaki Isohashi, Masahiko Koizumi,  and Kazuhiko Ogawa
633-646
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition

SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition

https://doi.org/10.18632/oncotarget.26567

Esteban A. Terzo, Aaron R. Lim, Anna Chytil, Yun Chen Chiang, Leah Farmer, Kathryn H. Gessner, Cheryl Lyn Walker, Valerie M. Jansen,  and W. Kimryn Rathmell
647-659
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone

Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone

https://doi.org/10.18632/oncotarget.26578

Florent Tixier, Hyemin Um, Dalton Bermudez, Aditi Iyer, Aditya Apte, Maya S. Graham, Kathryn S. Nevel, Joseph O. Deasy, Robert J. Young,  and Harini Veeraraghavan
660-672
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

https://doi.org/10.18632/oncotarget.26586

Koji Nakamura, Kenjiro Sawada, Mayuko Miyamoto, Yasuto Kinose, Akihiko Yoshimura, Kyoso Ishida, Masaki Kobayashi, Aasa Shimizu, Erika Nakatsuka, Kae Hashimoto, Seiji Mabuchi,  and Tadashi Kimura
673-683
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Corrections

Correction: Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer

Correction: Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer

https://doi.org/10.18632/oncotarget.26624

Shiqi Li, Yi Zhu, Zhen Liang, Xiao Wang, Shuai Meng, Xin Xu, Xianglai Xu, Jian Wu, Alin Ji, Zhenghui Hu, Yiwei Lin, Hong Chen, Yeqing Mao, Wei Wang, Xiangyi Zheng, Ben Liu,  and Liping Xie
684-684
Correction  |  PDF  |  How to cite

Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer

Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer

https://doi.org/10.18632/oncotarget.26625

Jonathan P. Evans, Boleslaw K. Winiarski, Paul A. Sutton, Robert P. Jones, Lorenzo Ressel, Carrie A. Duckworth, D. Mark Pritchard, Zhi-Xiu Lin, Vicky L. Fretwell, Elizabeth M. Tweedle, Eithne Costello, Christopher E. Goldring, Ian M. Copple, B. Kevin Park, Daniel H. Palmer,  and Neil R. Kitteringham
685-685
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC